Free Trial

Aadi Bioscience (AADI) News Today

Aadi Bioscience logo
$2.79 -0.07 (-2.45%)
Closing price 02/21/2025 04:00 PM Eastern
Extended Trading
$2.80 +0.00 (+0.18%)
As of 02/21/2025 06:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
3 US Penny Stocks With Market Caps Over $30M To Watch
Aadi Bioscience appoints Dornan as Chief Scientific Officer
Aadi Bioscience, Inc. stock logo
Peapod Lane Capital LLC Takes $1.40 Million Position in Aadi Bioscience, Inc. (NASDAQ:AADI)
Peapod Lane Capital LLC purchased a new position in shares of Aadi Bioscience, Inc. (NASDAQ:AADI - Free Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 442,942 shares of the company's stock, valued at
Aadi Bioscience, Inc. stock logo
Aadi Bioscience, Inc. (NASDAQ:AADI) Short Interest Update
Aadi Bioscience, Inc. (NASDAQ:AADI - Get Free Report) was the recipient of a significant growth in short interest during the month of January. As of January 31st, there was short interest totalling 706,400 shares, a growth of 49.4% from the January 15th total of 472,700 shares. Approximately 3.5% of the company's stock are short sold. Based on an average daily trading volume, of 357,800 shares, the short-interest ratio is currently 2.0 days.
Aadi Bioscience, Inc. stock logo
Short Interest in Aadi Bioscience, Inc. (NASDAQ:AADI) Decreases By 13.7%
Aadi Bioscience, Inc. (NASDAQ:AADI - Get Free Report) saw a large drop in short interest in January. As of January 31st, there was short interest totalling 472,700 shares, a drop of 13.7% from the January 15th total of 547,500 shares. Based on an average daily trading volume, of 349,100 shares, the days-to-cover ratio is currently 1.4 days. Approximately 2.3% of the company's shares are sold short.
Aadi Bioscience, Inc. stock logo
Aadi Bioscience, Inc. (NASDAQ:AADI) Sees Large Increase in Short Interest
Aadi Bioscience, Inc. (NASDAQ:AADI - Get Free Report) was the recipient of a large increase in short interest in the month of January. As of January 15th, there was short interest totalling 547,500 shares, an increase of 136.0% from the December 31st total of 232,000 shares. Approximately 2.7% of the company's stock are sold short. Based on an average daily trading volume, of 322,600 shares, the days-to-cover ratio is presently 1.7 days.
Aadi Bioscience, Inc. stock logo
Aadi Bioscience, Inc. (NASDAQ:AADI) Position Lowered by Jane Street Group LLC
Jane Street Group LLC lessened its holdings in Aadi Bioscience, Inc. (NASDAQ:AADI - Free Report) by 80.6% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 25,989 shares of the company's stock after se
Aadi Bioscience, Inc. stock logo
Aadi Bioscience, Inc. (NASDAQ:AADI) Short Interest Up 136.0% in December
Aadi Bioscience, Inc. (NASDAQ:AADI - Get Free Report) saw a significant growth in short interest in December. As of December 31st, there was short interest totalling 547,500 shares, a growth of 136.0% from the December 15th total of 232,000 shares. Currently, 2.7% of the shares of the stock are sold short. Based on an average daily volume of 322,600 shares, the days-to-cover ratio is currently 1.7 days.
Aadi Bioscience, Inc. stock logo
Aadi Bioscience (NASDAQ:AADI) Shares Down 16.1% - What's Next?
Aadi Bioscience (NASDAQ:AADI) Trading Down 16.1% - What's Next?
Aadi Bioscience Leads 3 Promising US Penny Stocks
Aadi Bioscience’s Strategic Agreements and Funding Moves
Aadi Bioscience rockets 72% on key updates
Aadi Bioscience, Inc. stock logo
Aadi Bioscience, Inc. (NASDAQ:AADI) Short Interest Down 8.8% in November
Aadi Bioscience, Inc. (NASDAQ:AADI - Get Free Report) was the target of a significant decrease in short interest in the month of November. As of November 15th, there was short interest totalling 256,500 shares, a decrease of 8.8% from the October 31st total of 281,100 shares. Based on an average daily volume of 148,600 shares, the short-interest ratio is currently 1.7 days. Currently, 1.3% of the shares of the company are sold short.
US Penny Stocks Under $90M Market Cap To Watch
Aadi Bioscience, Inc. stock logo
BML Capital Management LLC Buys Shares of 2,000,000 Aadi Bioscience, Inc. (NASDAQ:AADI)
BML Capital Management LLC bought a new stake in Aadi Bioscience, Inc. (NASDAQ:AADI - Free Report) during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 2,000,000 shares of the company's
Aadi Bioscience Reports Q3 2024 Earnings and Growth
Aadi Bioscience CEO sells shares worth $18,796
TD Cowen downgrades Aadi Bioscience (AADI) to a Hold
Aadi Bioscience Inc (3350.BE)
Aadi Bioscience earnings preview: what to expect
Get Aadi Bioscience News Delivered to You Automatically

Sign up to receive the latest news and ratings for AADI and its competitors with MarketBeat's FREE daily newsletter.

AADI Media Mentions By Week

AADI Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

AADI
News Sentiment

0.00

0.60

Average
Medical
News Sentiment

AADI News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

AADI Articles
This Week

3

1

AADI Articles
Average Week

Get Aadi Bioscience News Delivered to You Automatically

Sign up to receive the latest news and ratings for AADI and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:AADI) was last updated on 2/22/2025 by MarketBeat.com Staff
From Our Partners